U.S. Chemicals Stock News

Ever wondered if Xometry is truly worth its ever-climbing share price, or if today's headlines are making it too easy to get swept up in the hype? Xometry's stock price has swung notably lately, with a 3.8% gain over the past week but a 9.6% drop in the last month. It still boasts an impressive 157.6% rise over the past year. Recent news around Xometry has highlighted expanding industry partnerships and strategic deals, fueling investor optimism. Many see these developments as key drivers...

Encompass Health (NYSE:EHC) is on investors’ radar this week as the company prepares to release earnings. After topping revenue and earnings guidance last quarter, further growth is projected. This has added interest to recent expansion moves. See our latest analysis for Encompass Health. The past year has seen Encompass Health’s share price accelerate, climbing sharply with a 36.8% year-to-date share price return. The three-year total shareholder return stands at an impressive 138%. Recent...

Ever wondered if Roku stock is really living up to the streaming hype, or if there is untapped value hidden beneath the headlines? Shares have jumped 2.7% in the last week and are up a strong 32.4% for the year to date. However, they remain well below their five-year highs. Recent news has centered on Roku's continued expansion into smart TV partnerships and significant moves to secure new advertising deals, both of which have attracted investor attention. Along with market...

CleanSpark (CLSK) made headlines after announcing it acquired 271 acres in Texas and secured long-term power deals to support a next-generation data center campus focused on AI, cloud, and enterprise growth. This marks a bold step beyond bitcoin mining. See our latest analysis for CleanSpark. CleanSpark’s push into AI data centers and fresh executive appointments have energized the story, and investors have taken notice. The stock’s recent momentum is impossible to ignore, with a 27% share...

Wondering if Tradeweb Markets stock offers real value right now? You’re not alone, especially if you’re weighing its long-term growth against recent market noise. The share price has pulled back lately, dropping 4.4% in the past week and 5.3% over the last month, while the year-to-date return sits at -19.7% after a standout multi-year run. Fueling these moves, investor attention has shifted as tech-driven financial platforms continue to shake up traditional trading, with chatter around...

Commvault Systems (CVLT) posted a net profit margin of 7.3%, falling sharply from 19.7% the previous year, signaling a notable decline in profitability. Despite the recent pullback, the company has averaged 53.6% annual earnings growth over the last five years and is forecast to grow earnings by 18.7% and revenue by 11.4% per year, well ahead of wider US market trends. Investors are weighing the strong multi-year growth outlook against weaker recent margins and a lofty price-to-earnings...

Perfect (PERF) reported revenue forecasted to rise 12.9% per year, well above the US market average of 10.3%. EPS is projected to expand by 25.68% annually, also outpacing the broader market’s 15.7%. Profit margins narrowed slightly, with a current net profit margin of 8.5%, down from 9.1% last year, and profit growth for the year moderated to 6.6%, below the five-year average of 24.9%. Still, the company’s revenue and earnings trajectories continue to underpin a positive growth outlook,...

FMC (FMC) has landed in the spotlight after a string of tough announcements, including disappointing quarterly results, a lowered full-year revenue forecast, a reduced dividend, and confirmation that the company president is stepping down soon. See our latest analysis for FMC. While FMC has faced several setbacks in recent months, none have landed quite as hard as the recent results and leadership shakeup. Investors have responded swiftly, with the share price sliding 40% year-to-date and...

ResMed (NYSE:RMD) is gearing up to release its latest earnings this Thursday afternoon, which has caught the attention of investors. The company previously edged out revenue expectations, and this report could offer fresh insight. See our latest analysis for ResMed. ResMed’s share price has lost some traction in recent weeks, with a 6.43% decline over the past month, but the stock still shows momentum, delivering an 11% year-to-date share price return and a 5.3% total shareholder return over...

Equity Residential (EQR) booked a net profit margin of 37.5%, up from 31.5%, with earnings growth of 24.8% over the last year. This outpaces its 0.7% five-year average. The most recent results included a one-off gain of $691.9 million. Looking forward, revenue is forecast to rise at 4.2% per year, which is below the US market’s expected 10.2% annual pace. Despite a current share price of $58.91 that still trails the $86.18 fair value estimate, analysts remain cautious with a projected 17.9%...

Global Industrial (GIC) delivered net profit margins of 5.1%, a slight improvement from last year’s 4.9%, and posted earnings growth of 4.2% for the year after facing a five-year average decline of 0.8%. Shares are trading at $28.75, which sits well below one estimate of fair value at $49.02. High-quality earnings and lower-than-average valuation multiples are prompting investors to take a second look. With earnings projected to grow at 11.02% per year and no major risks identified, investors...

Booking Holdings (BKNG) delivered a notable earnings performance, with net profit margins at 19.4%, down from 21.8% a year ago, and annual EPS growth essentially flat at 0.2%. This is well below its robust five-year average of 39% per year. Looking ahead, management expects earnings to grow at roughly 20% per year, ahead of the broader US market’s 15.7% annual outlook, while revenue is projected to rise 8% per year compared to the market’s 10.3%. With a track record of outsized gains and an...

Amgen (AMGN) shares have generally moved sideways over the past month, with investors weighing recent financial performance and sector trends. The stock remains a steady point of interest for those following pharmaceuticals and biotech. See our latest analysis for Amgen. Amgen’s recent 1-month share price return of 6.5% signals some renewed momentum after a flat stretch. However, the 1-year total shareholder return remains down by 4.4%. While short-term gains have caught attention, the...

CVS Health Corporation reported third-quarter 2025 results with sales rising to US$33.72 billion and a net loss of US$3.98 billion, driven mainly by a US$5.73 billion goodwill impairment charge and ongoing financial headwinds. The company also lowered its full-year earnings guidance for 2025, highlighting that integration and cost pressures, including at Oak Street Health, are weighing on near-term profitability despite continued revenue growth. We'll examine how the significant goodwill...

Axogen (AXGN) caught investors’ attention after reporting a swing from net loss to profit in the third quarter and raising its 2025 revenue growth outlook. The company’s updated guidance and results signal growing confidence among management. See our latest analysis for Axogen. Momentum in Axogen’s stock has really taken off lately, with a 1-day share price return of 23.1% following the upbeat earnings and raised guidance. That surge builds on solid 30-day and 90-day share price returns of...

In recent days, analysts have issued negative commentary on Graphic Packaging Holding, pointing to ongoing declines in unit sales and shrinking earnings per share as major concerns for the company's outlook. This shift in analyst sentiment stands in contrast to positive coverage of some peers, emphasizing the unique pressures faced by Graphic Packaging Holding in its sector. We’ll examine how analyst concerns about declining unit sales and earnings could reshape Graphic Packaging Holding’s...

Modine Manufacturing (MOD) stock has shown steady gains over the past month, rising nearly 10%, with even stronger returns over the past 3 months. Investors may be assessing recent trends for fresh insights. See our latest analysis for Modine Manufacturing. Momentum has clearly been building for Modine Manufacturing. After a string of upbeat sessions, the stock price has climbed nearly 10% in the past month and delivered a 33.7% year-to-date share price return. Its three-year total...

Franklin Street Properties (FSP) continues its unprofitable streak, with losses worsening at an annual rate of 57.1% over the past five years. Forecasts indicate further unprofitability ahead. The company’s net profit margin shows no sign of improvement, and with no positive earnings catalysts, recent results offer little near-term relief for investors. This backdrop of growing losses is fueling a cautious market stance as concerns about dividend sustainability and overvaluation remain front...

Trustmark (TRMK) reported a standout year, with earnings leaping 536.2% compared to last year, a dramatic turnaround from its five-year average decline of 9.4% per year. Net profit margins also surged to 28.9% from just 6.3% twelve months ago. While future growth expectations are more muted, with forecasted EPS set to grow at 1.5% per year and revenue at 5.5% per year, both trailing the US market averages, investors will pay close attention to the company’s improved profitability, attractive...

Eagle Bancorp Montana (EBMT) delivered a notable jump in performance this quarter, with net profit margins climbing to 15.5% from 10.6% last year and annual earnings growth soaring to 59.1%. While forward estimates point to annual earnings expansion of 9.13%, revenue is forecast to dip by 3.3% per year over the next three years. Shares currently trade at $16.04, below estimated fair value on a discounted cash flow basis. With profit momentum, improved margins, and a price-to-earnings ratio of...

IQVIA Holdings (IQV) reported net profit margins of 8.1%, down from 9.2% last year, with last year’s earnings growth turning negative despite a five-year average earnings growth rate of 20.1% per year. Looking ahead, analysts forecast that earnings will grow at 13.99% per year and revenue at 5.3% annually, both of which are slower than the broader US market. For investors, that mixed results picture is complicated further by valuation measures suggesting the stock is attractively priced...

Aptiv (APTV) just unveiled its Gen 8 radar platform and PULSE Sensor, showcasing major advancements in automotive sensing, AI-powered perception, and cost efficiency. These moves could influence Aptiv’s future role across mobility and automation sectors. See our latest analysis for Aptiv. Aptiv’s rollout of breakthrough sensing tech comes as momentum steadily builds in the stock. A 42% year-to-date share price return hints at renewed optimism, while its one-year total shareholder return of...

Wondering if IDEXX Laboratories is trading at a price worth your attention? You are not alone, as investors continue to debate whether its current valuation truly matches future potential. Despite a brief dip of 1.0% over the last week and a minor decline over the past month, IDEXX shares have gained an impressive 53.5% year-to-date and are up nearly 40% in the past year. Recently, investor excitement has been fueled by developments in the veterinary diagnostics sector, including IDEXX's...

If you have ever wondered whether Paramount Skydance is fairly priced or if there is hidden value waiting to be uncovered, you are not alone. This stock has caught the attention of many curious investors lately. Paramount Skydance's share price has surged 50.1% year-to-date and is up 51.3% over the last 12 months, even after some recent turbulence with a 4.2% drop in the past week and an 18.6% slide over the last month. Much of this volatility has been driven by headline-making developments,...